Stempoint Capital’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
Stempoint Capital's BNTX Position: Q3 2026 in Review
Stempoint Capital opened a new position in BioNTech (BNTX) in Q3 2026: 42,200 shares worth $4.15M. The stake represents 0.74% of the portfolio and ranks #43 among its holdings. This is a return to the name: Stempoint Capital previously reported a position in BNTX as recently as Q4 2024.
Stempoint Capital first reported a position in BNTX in Q4 2024 and has held it in 2 quarters since. The position peaked at $7M in Q4 2024. 302 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.
- Stempoint Capital held 42,200 shares of BioNTech worth $4.15M as of Q3 2026.
- BioNTech was a new Stempoint Capital position in Q3 2026.
- BioNTech made up 0.74% of Stempoint Capital's portfolio in Q3 2026, its #43 holding.
- Stempoint Capital first reported a position in BioNTech in Q4 2024 and has held it in 2 quarters since.
- Stempoint Capital's BioNTech position peaked at $7M in Q4 2024.
- 302 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.
Based on Stempoint Capital's 13F filing for Q3 2026, filed 16 Nov 2026.